Is it time to Buy before this week’s earning report Avid Bioservices Stock Forecast, Price & News (NASDAQ:CDMO)

0
187

Earnings results for Avid Bioservices Stock Forecast, Price & News (NASDAQ:CDMO)

Avid Bioservices, Inc. is expected* to report earnings on 09/01/2020 after market close. The report will be for the fiscal Quarter ending Jul 2020. The reported EPS for the same quarter last year was $-0.08.

Avid Bioservices last announced its quarterly earnings results on June 30th, 2020. The biopharmaceutical company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. The company had revenue of $12.55 million for the quarter, compared to the consensus estimate of $9.55 million. Avid Bioservices has generated ($0.27) earnings per share over the last year. Avid Bioservices has confirmed that its next quarterly earnings report will be published on Tuesday, September 1st, 2020.

Analyst Opinion on Avid Bioservices Stock Forecast, Price & News (NASDAQ:CDMO)

4 Wall Street analysts have issued ratings and price targets for Avid Bioservices in the last 12 months. Their average twelve-month price target is $9.38, predicting that the stock has a possible upside of 11.74%. The high price target for CDMO is $11.00 and the low price target for CDMO is $7.50. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of “Buy.”

Avid Bioservices has received a consensus rating of Buy. The company’s average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $9.38, Avid Bioservices has a forecasted upside of 11.7% from its current price of $8.39. Avid Bioservices has only been the subject of 1 research reports in the past 90 days.

Dividend Strength: Avid Bioservices Stock Forecast, Price & News (NASDAQ:CDMO)

Avid Bioservices does not currently pay a dividend. Avid Bioservices does not have a long track record of dividend growth.

Insiders buying/selling: Avid Bioservices Stock Forecast, Price & News (NASDAQ:CDMO)

In the past three months, Avid Bioservices insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $39,484.00 in company stock. Only 1.72% of the stock of Avid Bioservices is held by insiders. 51.52% of the stock of Avid Bioservices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Avid Bioservices Stock Forecast, Price & News (NASDAQ:CDMO

Earnings for Avid Bioservices are expected to grow in the coming year, from ($0.23) to $0.11 per share. The P/E ratio of Avid Bioservices is -29.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Avid Bioservices is -29.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Avid Bioservices has a P/B Ratio of 11.34. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here